Authors: WEDGE SR PORTEOUS JK GLASER MG MARCUS K NEWLANDS ES

Citation: Sr. Wedge et al., IN-VITRO EVALUATION OF TEMOZOLOMIDE COMBINED WITH X-IRRADIATION, Anti-cancer drugs, 8(1), 1997, pp. 92-97

Authors: NEWLANDS ES OREILLY SM GLASER MG BOWER M EVANS H BROCK C BRAMPTON MH COLQUHOUN I LEWIS P RICEEDWARDS JM ILLINGWORTH RD RICHARDS PG

Citation: Es. Newlands et al., THE CHARING-CROSS-HOSPITAL EXPERIENCE WITH TEMOZOLOMIDE IN PATIENTS WITH GLIOMAS, European journal of cancer, 32A(13), 1996, pp. 2236-2241

Authors: LANE DM EAGLE KF BEGENT RHJ HOPESTONE LD GREEN AJ CASEY JL KEEP PA KELLY AMB LEDERMANN JA GLASER MG HILSON AJW

Citation: Dm. Lane et al., RADIOIMMUNOTHERAPY OF METASTATIC COLORECTAL TUMORS WITH IODINE-131-LABELED ANTIBODY TO CARCINOEMBRYONIC ANTIGEN - PHASE I II STUDY WITH COMPARATIVE BIODISTRIBUTION OF INTACT AND F(AB')(2) ANTIBODIES/, British Journal of Cancer, 70(3), 1994, pp. 521-525

Authors: OREILLY SM NEWLANDS ES GLASER MG BRAMPTON M RICEEDWARDS JM ILLINGWORTH RD RICHARDS PG KENNARD C COLQUHOUN IR LEWIS P STEVENS MFG

Citation: Sm. Oreilly et al., TEMOZOLOMIDE - A NEW ORAL CYTOTOXIC CHEMOTHERAPEUTIC AGENT WITH PROMISING ACTIVITY AGAINST PRIMARY BRAIN-TUMORS, European journal of cancer, 29A(7), 1993, pp. 940-942